Literature DB >> 20096616

False-positive results using a Gaucher diagnostic kit--RecTL and N370S.

Jae Hyuk Choi1, Arash Velayati, Barbara K Stubblefield, Avi Orr-Urtreger, Ziv Gan-Or, Nahid Tayebi, Ellen Sidransky.   

Abstract

The Pronto Gaucher kits and Pronto Gaucher RecTL Amplification Mix, marketed to identify mutations in the gene for glucocerebrosidase, are widely used for the diagnosis of Gaucher disease. Subjects genotyped using this kit have been reported with an allele including both the common N370S mutation and RecTL, a previously described Gaucher mutation arising from recombination between the glucocerebrosidase gene and pseudogene. Using direct sequencing and real-time PCR, we show that the RecTL, N370S allele is a false positive result, demonstrating possible pitfalls of diagnostic kits. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096616      PMCID: PMC2854310          DOI: 10.1016/j.ymgme.2009.12.017

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  10 in total

1.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

2.  Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.

Authors:  M Horowitz; M Pasmanik-Chor; Z Borochowitz; T Falik-Zaccai; K Heldmann; R Carmi; R Parvari; H Beit-Or; B Goldman; L Peleg; E Levy-Lahad; P Renbaum; S Legum; R Shomrat; H Yeger; D Benbenisti; R Navon; V Dror; M Shohat; N Magal; N Navot; N Eyal
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

Review 3.  Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.

Authors:  D L Stone; N Tayebi; E Orvisky; B Stubblefield; V Madike; E Sidransky
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease.

Authors:  A Zimran; M Horowitz
Journal:  Am J Med Genet       Date:  1994-03-01

5.  Non-radioisotopic typing of human leukocyte antigen class II genes on microplates.

Authors:  R Giorda; V Lampasona; M Kocova; M Trucco
Journal:  Biotechniques       Date:  1993-11       Impact factor: 1.993

6.  Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.

Authors:  Nahid Tayebi; Barbara K Stubblefield; Joseph K Park; Eduard Orvisky; Jamie M Walker; Mary E LaMarca; Ellen Sidransky
Journal:  Am J Hum Genet       Date:  2003-02-13       Impact factor: 11.025

7.  Gaucher disease: gene frequencies in the Ashkenazi Jewish population.

Authors:  E Beutler; N J Nguyen; M W Henneberger; J M Smolec; R A McPherson; C West; T Gelbart
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

Review 8.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

9.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.

Authors:  Z Gan-Or; N Giladi; U Rozovski; C Shifrin; S Rosner; T Gurevich; A Bar-Shira; A Orr-Urtreger
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

10.  Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.

Authors:  E Beutler; T Gelbart; W Kuhl; J Sorge; C West
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

  10 in total
  4 in total

1.  Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.

Authors:  Ziv Gan-Or; Anat Bar-Shira; Tanya Gurevich; Nir Giladi; Avi Orr-Urtreger
Journal:  Neurogenetics       Date:  2011-08-12       Impact factor: 2.660

2.  Identification of recombinant alleles using quantitative real-time PCR implications for Gaucher disease.

Authors:  Arash Velayati; Melanie A Knight; Barbara K Stubblefield; Ellen Sidransky; Nahid Tayebi
Journal:  J Mol Diagn       Date:  2011-07       Impact factor: 5.568

3.  Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.

Authors:  G Eisenhofer; C D Vocke; A Elkahloun; T-T Huynh; T Prodanov; J W M Lenders; H J Timmers; J N Benhammou; W M Linehan; K Pacak
Journal:  Horm Metab Res       Date:  2012-03-21       Impact factor: 2.936

4.  Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease.

Authors:  Jennifer A Ruskey; Lior Greenbaum; Léanne Roncière; Armaghan Alam; Dan Spiegelman; Christopher Liong; Oren A Levy; Cheryl Waters; Stanley Fahn; Karen S Marder; Wendy Chung; Gilad Yahalom; Simon Israeli-Korn; Vered Livneh; Tsvia Fay-Karmon; Roy N Alcalay; Sharon Hassin-Baer; Ziv Gan-Or
Journal:  Eur J Med Genet       Date:  2018-05-26       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.